Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT02458014
What this trial is testing

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Who this might be right for
Adult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT02523976
What this trial is testing

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute,Leukemia, Lymphoid
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Large-scale testing (Phase 3)UnknownNCT03624530
What this trial is testing

Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaTyrosine Kinase InhibitorMinimal Residual Disease+1 more
Nanfang Hospital, Southern Medical University 82
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Large-scale testing (Phase 3)UnknownNCT02611492
What this trial is testing

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

Who this might be right for
Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris 265
Testing effectiveness (Phase 2)Ended earlyNCT00905398
What this trial is testing

Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia
Rony Schaffel 8
Testing effectiveness (Phase 2)Study completedNCT02067143
What this trial is testing

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate

Who this might be right for
Untreated Philadelphia Positive Acute Lymphoblastic LeukemiaDe NovoSecondary+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 204
Testing effectiveness (Phase 2)WithdrawnNCT01670084
What this trial is testing

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more
Mayo Clinic
Testing effectiveness (Phase 2)UnknownNCT05466175
What this trial is testing

Olverembatinib in the Treatment of Ph+ ALL

Who this might be right for
Philadelphia-Positive ALL
Chen Suning 55
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00702403
What this trial is testing

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more
Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)UnknownNCT04375683
What this trial is testing

Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL

Who this might be right for
Acute Lymphocytic Leukemia, Adult B-CellBCR-ABL1 Fusion Protein Expression
Zhongda Hospital 28
Testing effectiveness (Phase 2)UnknownNCT00199186
What this trial is testing

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia Positive Acute Lymphoblastic LeukemiaLymphoid Blastic Phase of Chronic Myeloid Leukemia
Johann Wolfgang Goethe University Hospital
Early research (Phase 1)Study completedNCT01925131
What this trial is testing

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineageB-cell Adult Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia+2 more
SWOG Cancer Research Network 50
Testing effectiveness (Phase 2)Study completedNCT01460160
What this trial is testing

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Pediatric
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Temporarily pausedNCT03739814
What this trial is testing

Inotuzumab Ozogamicin and Blinatumomab in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 64
Not applicableStudy completedNCT03678454
What this trial is testing

Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium

Who this might be right for
Chronic Myeloid LeukemiaCMLPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia+1 more
Incyte Biosciences Benelux 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982
What this trial is testing

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more
M.D. Anderson Cancer Center 88
Load More Results